MedTrace Logo

Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate

NCT01755481 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2018-01-17

No results posted yet for this study

Summary

To evaluate the effects of feeding an infant formula containing L. paracasei ssp. paracasei strain F19 or Whey Protein Concentrate.

Conditions

  • Focus on Healthy Infants

Interventions

OTHER

Probiotic

OTHER

Whey protein concentrate

Sponsors & Collaborators

  • Arla Foods

    lead INDUSTRY

Principal Investigators

  • Yongmei Peng, M.D., Ph.D. · Children's Hospital, Fudan University, Shanghai, China

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
2 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01755481 on ClinicalTrials.gov